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Posttranslational modifications play central roles
in myriad biological pathways including circadian
regulation. We employed a circadian proteomic
approach to demonstrate that circadian timing of
phosphorylation is a critical factor in regulating
complex GSK3b-dependent pathways and identified
O-GlcNAc transferase (OGT) as a substrate of
GSK3b. Interestingly, OGT activity is regulated by
GSK3b; hence, OGT and GSK3b exhibit reciprocal
regulation. Modulating O-GlcNAcylation levels alter
circadian period length in both mice and Drosophila;
conversely, protein O-GlcNAcylation is circadianly
regulated. Central clock proteins, Clock and Period,
are reversibly modified by O-GlcNAcylation to regu-
late their transcriptional activities. In addition,
O-GlcNAcylation of a region in PER2 known to regu-
late human sleep phase (S662–S674) competes with
phosphorylation of this region, and this interplay is at
least partly mediated by glucose levels. Together,
these results indicate that O-GlcNAcylation serves
as a metabolic sensor for clock regulation and works
coordinately with phosphorylation to fine-tune circa-
dian clock.
INTRODUCTION
Circadian rhythms in physiology and behavior are present in
a variety of organisms from plants and bacteria to humans.
These rhythms are controlled by endogenous molecular clocks
even in the absence of external cues (e.g., light). The fact that
circadian clocks are evolutionarily conserved supports the
view that precise rhythms are essential for organisms to survive.
Perturbations of circadian rhythms and sleep have been associ-
ated with many human ailments such as metabolic syndrome,
cardiovascular disease, depression, epilepsy, and cancer
(Bass and Takahashi, 2010; Climent et al., 2010; Duez and
Staels, 2010; Wulff et al., 2010).Cell MGlycogen synthase kinase 3b (GSK3b) is an important sig-
naling mediator that has central functions in diverse physiolog-
ical pathways including transcription, cell-cycle regulation,
metabolism, development, neuronal function, and oncogenesis,
among others (Rayasam et al., 2009). These diverse functions of
GSK3b can be attributed to the large number of substrates it can
phosphorylate. GSK3b is a constitutively active serine/threonine
kinase with a preference for primed substrates and is inactivated
in response to multiple stimuli by phosphorylation at S9 (Cohen
and Frame, 2001). GSK3b is also a crucial circadian clock regu-
lator (Iitaka et al., 2005; Martinek et al., 2001). Lithium (a GSK3b
inhibitor) treatment lengthens the circadian period and delays
the phase of rhythmic clock gene expression (Abe et al., 2000;
Iitaka et al., 2005), although a recent report showed that inhibi-
tion of GSK3b activity by small molecule inhibitors or siRNAs
shortens the circadian period (Hirota et al., 2008). In order to
further understand the effects of GSK3b activity on various
biological pathways in general and circadian regulation in partic-
ular, we employed a proteomic approach to elucidate the com-
plexity of the GSK3b circadian phosphoproteome. Interestingly,
we identified O-GlcNAc transferase (OGT) from the chemical-
genetic proteomic screen as a substrate of GSK3b. GSK3b
was previously shown to be O-GlcNAcylated by OGT in vitro
(Lubas and Hanover, 2000). Since our data suggest that OGT
andGSK3b regulate each other andGSK3b is a critical molecular
clock component, we investigated the possibility of O-GlcNAcy-
lation as a regulatory posttranslational modification in circadian
regulation.
O-linked N-acetylglucosamine (O-GlcNAc) glycosylation has
emerged as one of the most common protein posttranslational
modifications with the second most abundant high-energy
compound, UDP-GlcNAc, as the direct donor. Two enzymes
regulate O-GlcNAcylation: the OGT attaches UDP-GlcNAc to
the serine and threonine residues of proteins through a beta-
glycosidic O-linkage, while O-GlcNAcase (OGA) hydrolyzes
O-GlcNAc from proteins (Hart et al., 2011). OGT and OGA are
highly regulated to prevent unnecessary O-GlcNAc cycling (Se-
kine et al., 2010). Here we report thatO-GlcNAcylation and circa-
dian clock are reciprocally regulated and that O-GlcNAcylation
modulates CLOCK-dependent transcriptional activity by post-
translationally regulating components of the molecular clock.etabolism 17, 291–302, February 5, 2013 ª2013 Elsevier Inc. 291
Figure 1. Characterization of GSK3b by ATP Analog-Specific Chemical-Genetic Method
(A) Representative double-plotted actograms of daily wheel-running activity for GSK3bAS/AS and WT littermate mice. 1-Na-PP1 treatment was initiated after
1 week in constant darkness and administered daily for a week. The arrow on each actogram indicates the beginning of inhibitor treatment. 1-Na-PP1 treatment
lengthens the circadian period of GSK3bAS/AS mice in constant darkness from t = 24.0 ± 0.12 hr (no inhibitor; n = 10) to t = 24.5 ± 0.1 hr (with inhibitor; n = 6,
p < 0.01). 1-Na-PP1 treatment does not affect circadian period length in WT littermates (t = 23.7 ± 0.15 hr [no inhibitor; n = 10] versus t = 23.5 ± 0.07 hr [with
inhibitor; n = 6]).
(B) Western blot demonstrates that pS9 of GSK3b oscillates at different phases in different tissues with the phase of hippocampus antiphase to the phase of liver.
(C) In vitro kinase reactions show thatWTGSK3b is unable to utilize N-6-modified ATPgS analogs (lanes 2 and 3) as phosphodonors but utilizes ATPgS (lane 1). AS
GSK3b (L132G) efficiently utilizes both unmodified (lane 4) and N-6-modified ATPgS analogs (lanes 5 and 6) and prefers N-6-phenethyl ATPgS (lane 6). Loading
controls for the substrate myelin basic protein (MBP) and GSK3b are included.
(D) GSK3b demonstrates antiphase phosphorylation of substrates in hippocampal versus liver tissue. AS GSK3b kinase was added to the protein extracts, and
kinase assays were performed in the presence of N-6-phenethyl ATPgS. After PNBM alkylation, western blot analysis was performed using the antibodies
indicated. Blots for glyceraldehyde phosphate dehydrogenase (GAPDH) demonstrate equal loading. See also Figures S1, S2, and S7 and Tables S1, S2, and S3.
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O-GlcNAc-Phospho Interplays in Circadian ClockIn addition, O-GlcNAcylation interplays with phosphorylation on
PER2, which likely plays a role in fine-tuning clock speed.
RESULTS
Rhythmic Phosphorylation of GSK3b Substrates
We developed an ATP analog-specific (AS) chemical-genetic
approach to identify direct GSK3b substrates that are involved
in circadian regulation and coupling of core clock components
to input-output pathways. To verify the effect of GSK3b on the
circadian clock in vivo, we obtained AS GSK3b knockin mice
(GSK3bAS/AS, TaconicArtemis). Using analogs of the general
kinase inhibitor (PP1) that specifically inhibit AS, but not wild-
type (WT) kinases, kinase activity can be specifically, rapidly,
and reversibly inhibited (Bishop et al., 2000). Wheel-running
activity of GSK3bAS/AS mice was analyzed after entrainment in
a 12 hr light/12 hr dark cycle (12L/12D) for 1 week. These mice
showed a statistically significant lengthening of period versus292 Cell Metabolism 17, 291–302, February 5, 2013 ª2013 Elsevier InWT controls (24 versus 23.7 hr) in constant darkness (DD) (Fig-
ure 1A), suggesting that the engineered mutation produces an
AS GSK3b kinase with altered enzyme activity. This is consistent
with the observation that AS GSK3b enzyme activity is reduced
when compared with WT GSK3b by an in vitro kinase assay
(Figures S1A and S1B). AS GSK3b is inhibited by the 1-Na-PP1
inhibitor both in vitro in a concentration-dependent manner (Fig-
ure S1C) and in vivo (Figure S1E), whereas WT GSK3b is not
affected by 1-Na-PP1. Interestingly, after treatment with the
AS GSK3b inhibitor (1-Na-PP1), the period was further length-
ened to 24.5 hr (versus 24 hr in GSK3bAS/AS without inhibitor; Fig-
ure 1A). This finding is congruent with previous data using lithium
(Abe et al., 2000; Duez and Staels, 2008). Since lithium acts on
targets other than GSK3b (O’Brien and Klein, 2009), the data
from the GSK3bAS/AS mice suggest that specific inhibition of
GSK3b leads to lengthening of the circadian period.
GSK3b S9 phosphorylation (inactive GSK3b) demonstrates
robust circadian oscillation (Iitaka et al., 2005). In order to testc.
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O-GlcNAc-Phospho Interplays in Circadian Clockthe oscillation of GSK3b S9 phosphorylation in both brain and
peripheral tissues, hippocampus and liver tissues were obtained
from WT mice (Figure 1B). Hippocampus was used instead of
suprachiasmatic nucleus (SCN) due to the ease of anatomical
dissection and the need to obtain a sufficient quantity of tissue
for proteomic analysis. Phosphorylation of GSK3b S9 in hippo-
campus peaks at subjectivemorning (circadian time [CT] 0, lights
on or ‘‘dawn’’ in the light/dark cycle) and is antiphase to liver
where it peaks at subjective evening (CT12, lights off or ‘‘dusk’’
in the light/dark cycle), consistent with previous findings that
kinases demonstrate tissue-specific and time-specific activities
(Kategaya et al., 2012). To analyzewhether GSK3b activity corre-
lates with the substrates it phosphorylates, we isolated protein
extracts from the hippocampus and liver of WT mice at CT0
and CT12. Recombinant AS GSK3bwas added to hippocampus
and liver protein extracts together with N6-phenethyl ATPgS. AS
GSK3b enzyme prefers ATPgS analogs (N6-benzyl ATPgS and
N6-phenethyl ATPgS) as thiophospho-donors, whereas these
analogs are not accepted by WT GSK3b (Figure 1C). Thiophos-
phorylated substrates are then alkylated for recognition by a
thiophosphate ester-specific antibody (Figures S2A and S2B)
(Allen et al., 2005). Substrate phosphorylation patterns by AS
GSK3b showed dramatic differences between the two tissues
and at different CTs when assessed by western blotting (Fig-
ure 1D). The intensity of substrate phosphorylation directly
correlated with the GSK3b activity in a circadian manner (the
time point with high GSK3b activity in each tissue also showed
the highest phosphorylation of substrates).
Analog-Specific GSK3b Substrate Identification
We performed kinase reactions of analog-specific substrate
labeling by recombinant AS GSK3b to identify targets from the
liver and hippocampus proteomes (at time of peak GSK3b-medi-
ated phosphorylation CT0 in liver and CT12 in hippocampus)
(see Figure 1D). This procedure was performed three times
with protein extracts from mouse hippocampus and twice with
extracts from mouse liver. In the samples with AS GSK3b, 343
and 124 potential GSK3b substrates were identified by mass
spectrometry (MS) from the hippocampus and liver, respectively.
Eighty-six of these proteins were found in both (Tables S1 and
S2). Of the 343 and 124 proteins in these tissues, 145 and 69
of them were found only in samples with AS GSK3b, but not in
samples with WT GSK3b, and 30 of them were identified in
both the hippocampus and liver (Tables S1 and S3). To validate
the effectiveness of this approach, we experimentally examined
two proteins, zona occludens protein 1 (ZO1, Figure S2C) and
PPP1R9B (Figures 2A and S2D), and confirmed them as
substrates of GSK3b. Results from detailed bioinformatic anal-
yses for the proteomic screens can be found in Tables S1, S2,
and S3. Proteins identified in the AS GSK3b hippocampus-posi-
tive-only and AS GSK3b liver-positive-only were further exam-
ined in the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database (http://www.genome.jp/kegg) to reveal path-
ways that are potentially regulated by GSK3b (Figure S7).
Many previously known GSK3b-involved pathways, together
with additional pathways, were found through this approach,
further highlighting the interconnectedness of various regulatory
mechanisms. Collectively, these results suggest that daily timing
is an important parameter controlling GSK3b substrate speci-Cell Mficity and that tissue-specific circadian phosphoregulation of
GSK3b substrates may play important roles in the regulation of
GSK3b-dependent physiological pathways.
GSK3b Regulates OGT Activity
Intriguingly, OGT was one of the GSK3b substrates that was
identified in the chemical-genetic screen (Table S1 and Fig-
ure S2E). The covalent dynamic modification of O-GlcNAc to
proteins by OGT has emerged as a common posttranslational
modification that is as abundant as phosphorylation within the
nucleus and cytoplasm (Torres and Hart, 1984). To validate
OGT as an authentic GSK3b substrate, OGTwas immunoprecip-
itated from brain extracts of WT mice using anti-OGT antibody.
The precipitants were then subjected to WT or AS GSK3b kinase
reactions with the ATPgS N6-benzyl analog followed by SDS-
PAGE, and western blots were probed with thiophosphate
ester-specific antibody. In the presence of ATPgS N6-benzyl
analog, OGT was phosphorylated by AS GSK3b (Figure 2A).
In addition, OGT was phosphorylated by GSK3b using in vitro
32P-labeled ATP (Figure 2B), demonstrating that OGT is
a GSK3b substrate.
Mass spectrometry was then employed to identify where
GSK3b phosphorylates OGT. OGT, in the presence or absence
of GSK3b, was digested with trypsin before the peptides were
analyzed by tandem mass spectrometry to identify modified
peptides. OGT was found to be phosphorylated on S3 or S4
(data could not distinguish between these potential sites) (Fig-
ure 2C, left panel). Extracted ion chromatograms for the intensity
of this phosphorylated peptide in the two samples showed a
significant increase in the presence of GSK3b, suggesting that
this site is modified by GSK3b (Figure 2C, right panel). Interest-
ingly, MS analysis also revealed that both S3 and S4 (but
probably not at the same time) of OGT can be O-GlcNAc modi-
fied (Figure 2D). Hence, phosphorylation by GSK3b and
O-GlcNAcylation must compete with and regulate each other
at this N-terminal site of OGT.
OGT activity was next measured in the presence and absence
of GSK3b to reveal whether phosphorylation byGSK3b regulates
OGT activity. Indeed, OGT activity was enhanced with the pres-
ence of GSK3b phosphorylation (Figure 2E, OGT versus pOGT).
To test whether phosphorylation of S3 and S4 on OGT by GSK3b
is responsible for the enhanced activity, we mutated S3 and S4
to either alanine or aspartate (tomimic a constitutively phosphor-
ylated state) before the kinase assays. Increased OGT activity by
GSK3b was blocked when S3 and S4 were mutated to alanine,
providing evidence that phosphorylation on these two amino
acids is necessary for the effect of GSK3b on OGT. Interestingly,
when S3 and S4 were mutated to aspartate, OGT activity
increased slightly in the absence of GSK3b but significantly in
the presence of GSK3b, suggesting that other phosphorylation
sites on OGT are needed for the complete activation of OGT
activity by GSK3b.
Manipulating O-GlcNAcylation Levels Regulates Period
Length in Both Mice and Drosophila
Since cyclic posttranslational modifications such as phosphory-
lation (Chiu et al., 2011; Xu et al., 2007), acetylation (Hirayama
et al., 2007), SUMOylation (Cardone et al., 2005), and poly(ADP-
ribosyl)ation (Asher et al., 2010) are known to regulate clocketabolism 17, 291–302, February 5, 2013 ª2013 Elsevier Inc. 293
Figure 2. OGT Activity Is Regulated by GSK3b
(A) Kinase assays for mouse brain extracts from WT GSK3b or AS GSK3b were visualized by silver staining (top right panel) or by western blot against
thiophosphate ester antibody (top left panel). Western blots of the same brain extracts probed with antibodies against GSK3b, OGT, and PPP1R9B (middle
panels). Kinase reactions of brain extracts were immunoprecipitated by antibodies for PPP1R9B or OGT, followed by western blot against thiophosphate ester
antibody (bottom panel). PPP1R9B and OGT were specifically phosphorylated by AS GSK3b, but not by WT GSK3b.
(B) In vitro phosphorylation of OGT by GSK3b in the presence of radioactive ATP (left panel). Proteins used were detected by western blotting probed with
anti-OGT and anti-GSK3b antibodies (right panel).
(C) Increased phosphorylation of OGT N-terminal peptide by GSK3b. Extracted ion chromatograms of the mass-to-charge (m/z) ratio of the phosphorylated
version of the tryptic peptide spanning residues 2–17 of the protein OGT shows a significantly increased level upon GSK3b treatment (right panel). CID
fragmentation spectrum determines the phosphorylation to be present on either S2 or S3 of the peptide (i.e., S3 or S4 of the OGT protein) (left panel).
(D) OGT can beO-GlcNAc modified on S2 or S3 of the peptide. Electron-transfer dissociation (ETD) fragmentation spectrum of a singly GlcNAc-modified version
of the tryptic peptide spanning residues 2–17 of the protein OGT shows amixture spectrum, demonstratingmodified versions where S2 and S3 of the peptide are
both present.
(E)O-GlcNAcylation in vitro assay.O-GlcNAc transferase activity was measured using affinity-purified OGT, in the presence or absence of GSK3b, and UDP-[3H]
GlcNAc. OGT activity was enhanced by the presence of GSK3b (pOGT). S3 and S4 of OGT weremutated to either alanine (S3AS4A) or aspartate (S3DS4D) for the
assay. CKII peptide and control peptide were used as substrates in the assay. 3HDPM: 3H Disintegrations per minute. Error bars indicate the mean ± SE.
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2009), we investigated whether O-GlcNAcylation affects circa-
dian rhythmicity. We first used primary embryonic fibroblast cells
from Per2-luciferase mice (Yoo et al., 2005) and synchronized
them with glucocorticoids followed by treatment with PUGNAc
(OGA inhibitor), Alloxan (OGT inhibitor), or a pool of four
siRNAs against OGT. Interestingly, OGT inhibitor and OGT
siRNA (decreased O-GlcNAcylation) shortened, while OGA
inhibitor (increased O-GlcNAcylation) lengthened the circadian
rhythmicity of Per2-Luc oscillation (Figures 3A, 3B, and S3C).
We then confirmed period shortening with OGT conditional
knockout mice (Figures 3C, S3A, and S3B) to reduce OGT levels
in vivo (knockout of OGT in mice causes early embryonic
lethality) (Shafi et al., 2000).
Next, we asked whether O-GlcNAcylation is conserved as
a regulatory mechanism in Drosophila circadian clock. We
crossed tim(UAS)-Gal4 (Martinek et al., 2001) with UAS-RNAiOgt
or UAS-RNAiOga to downregulate and UAS-Ogt or UAS-Oga to
overexpress OGT and OGA, respectively, in Drosophila for294 Cell Metabolism 17, 291–302, February 5, 2013 ª2013 Elsevier Inbehavioral analyses. Ogt knockdown and Oga overexpression
both resulted in period shortening, while Oga knockdown and
Ogt overexpression both led to period lengthening (Figures 3D
and S3D). Together, these results suggested that O-GlcNAcyla-
tion is regulating the circadian clock in mice and flies and raised
the possibility that clock proteins may be the direct targets of
O-GlcNAcylation.
O-GlcNAc Modification of Drosophila and Mammalian
Clock Components
Using Drosophila Schneider 2 (S2) cell culture, we identified that
dClk and dPer areO-GlcNAcylated (Figures 4A and 4B). dClk-V5
coimmunoprecipated with Ogt and Oga (Figure 4C) from S2
cells, supporting the possibility that dClk is a target of Ogt/
Oga-dependent, reversible O-GlcNAcylation. To show that
mammalian clock proteins are also O-GlcNAc modified, human
PER2-His and human OGT-Flag were coexpressed. PER2 was
detected byO-GlcNAc antibody after anti-His immunoprecipita-
tion, whereas O-GlcNAcylated PER2 was not detected in thec.
Figure 3. O-GlcNAcylation Levels Regulate Period Length
(A) Alloxan (1 mM; OGT inhibitor) shortens (22.2 hr ± 19 min) and PUGNAc (100 mM; OGA inhibitor) lengthens (25.6 hr ± 15 min) the circadian period of primary
fibroblasts extracted from Per2-Luc reporter mice. For control, the periods of Per2-Luc fibroblasts were measured as 24.2 hr ± 21 min. Concentrations of Alloxan
and PUGNAc were experimentally tested in pilot experiments (data not shown). A representative of experiments repeated in triplicate is illustrated.
(B) A pool of fourOGT siRNAs shortensPer2-Luc fibroblast periods to 22.5 hr ± 20min compared to the control siRNA pool at 24.4 hr ± 30min. A representative of
experiments repeated in triplicate is illustrated. OGT andO-GlcNAc levels in the control and siRNA cells were determined by western blotting shown to the right.
(C) OGTF/Y-rtTA-actin/tetO-cre (conditional knockout) and OGTF/Y/tetO-cre (control) mice were entrained in a 12 hr dark/12 hr light cycle. The mice were re-
leased to constant darkness before doxycycline (2 mg/ml) was supplemented into drinking water. Representative locomotor activity recordings of indicated
mouse genotypes are presented. For visualization, 2 days are plotted per row. Quantifications of period length by hours are shown in the right panel. n = 8 for both
mice genotypes.
(D) Representative locomotor activity recordings and periodograms of indicated fly genotypes over circadian time. For visualization, 2 days are plotted per row.
On top of the panels, the subjective light (gray bar) and dark (black bar) phases are indicated. Numbers in the oscillation graphs indicate t, the expressed period of
the free-running rhythm in constant darkness, of flies with the indicated genotype. Details and quantifications are specified in Table S4. Controls for (A), (C), and
(D) are shown in Figure S3. Error bars represent SEM. See also Figure S3.
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cylation of PER2 is specific (Figure 4D). In the presence of
OGA inhibitor (PUGNAc) in the lysis buffer, PER2-His was also
detected as O-GlcNAc modified without cotransfection with
OGT, further supporting that PER2 ismodified byO-GlcNAc (Fig-
ure 4E). Immunoprecipitation was next performed with mouse
liver extracts using anti-O-GlcNAc antibody, and western blot
analysis indicated O-GlcNAcylation of both mouse PER2 and
OGT in vivo (Figure 4F). Similarly, mouse CLOCK is likely
O-GlcNAcylated by OGT and de-O-GlcNAcylated by OGA in
HEK293 cells (Figure 4G). Usingmouse liver extracts, OGA coim-
munoprecipitated with CLOCK at circadian times CT8 and CT20
(Figure 4H), indicating that CLOCK interacts with OGA and is
likely a target of OGT/OGA-dependent O-GlcNAcylation.
O-GlcNAcylation Modulates dClk and dPer
Transcriptional Activities
To gain further insight into the effect of O-GlcNAcylation on dClk
in circadian regulation, we employed a luciferase assay to
measure dClk-dependent E-box activation of the per promoterCell Min the presence of Ogt or Oga (Figure 5A) and demonstrated
that de-O-GlcNAcylated dClk activates and O-GlcNAcylated
dClk represses E-box-dependent per-luc activation more than
basal dClk (i.e., without exogenous Ogt or Oga). Interestingly,
the transcriptional activity of dClk when dClk and dPer are
both de-O-GlcNAcylated is similar to the activity of dClk without
dPer, and the repressive effect of dPer is further enhanced when
dClk and dPer are both O-GlcNAcylated, implying that Ogt
enhances and Oga relieves dPer-dependent per-luc inhibition
through dClk. These results demonstrate that O-GlcNAc modifi-
cation of dClk transcriptional activity is integral for regulation of
the molecular clock.
Since O-GlcNAcylation modulates dClk transcriptional
activity, we next measured dTim and dPer levels. When Ogt is
overexpressed (i.e., reduced dClk transcriptional activity), both
dTim and dPer levels were reduced compared to control flies,
and their rhythm phases showed a subtle trend of delay in clock
neurons (Figures 5B and S4B). On the other hand,Ogt RNAi (i.e.,
increased dClk transcriptional activity) resulted in increased
dTim and dPer protein (Figure 5C) and RNA levels (Figure 5D),etabolism 17, 291–302, February 5, 2013 ª2013 Elsevier Inc. 295
Figure 4. O-GlcNAcylationofClockProteins
(A) dClk-V5 was transfected into S2 cells alone
or together with Ogt-Flag or Oga-Flag followed
by dClk-V5 pull-down and O-GlcNAc western
analysis.
(B) dPer-myc was transfected into S2 cells alone
or together with Ogt-Flag or Oga-Flag followed
by dPer-myc pull-down and O-GlcNAc western
analysis.
(C) dClk-V5 was transfected into S2 cells alone or
together with Ogt-Flag or Oga-Flag, and dClk-V5
pull-down was performed using V5. Western blot
was performed with Flag antibody. IgG was used
as negative control for pull-down.
(D) Human PER2 (PER2) is O-GlcNAcylated in
HEK293 cells (upper panel). GlcNAc in the western
buffer blocks the interaction of O-GlcNAc anti-
body with PER2, indicating that PER2 is
O-GlcNAcylated (middle panel).
(E) hPER2-His or empty plasmids were trans-
fected into HEK293 cells, and pull-down was
performed with His or V5 antibodies. The OGA
inhibitor PUGNAc was included in the lysis buffer,
and western blot was probed with O-GlcNAc (left
panel) or PER2 (right panel) antibodies. In the
presence of PUGNAc, PER2 is O-GlcNAcylated
without additional OGT (left panel). Cells trans-
fected with empty plasmids were included as
negative controls.
(F) Western analysis for immunoprecipitants using
anti-O-GlcNAc frommouse liver extracts with anti-
PER2 (mouse PER2) and anti-OGT antibodies
demonstrate that PER2 is O-GlcNAc modified.
OGT is auto-O-GlcNAcylated and serves as
a positive control. IP with IgG was used as a
negative control.
(G) mCLOCK (CLK) isO-GlcNAcylated by OGT and de-O-GlcNAcylated by OGA. CLK-Flag was transfected into HEK293 cells either alone or together with OGA
or OGT-V5 followed by Flag pull-down and O-GlcNAc western analysis.
(H) CLOCK protein interacts with OGA in themouse liver. CLOCK protein was immunoprecipitated from themouse liver at CT8 andCT20.Western blot of the CLK
pull-down was probed with CLK and OGA antibodies (bottom panel). Inputs are shown over the time course including CT8 and CT20 (top panel).
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together, these results point to the necessity for balanced OGA
and OGT activities and tightly controlled levels of O-GlcNAc-
modified clock components for proper clock function.
Competition of O-GlcNAcylation and Phosphorylation
for the PER2 S662–S674 Region
Human PER2 S662–S674 is a critical site for regulating clock
speed by serial phosphorylation of multiple residues; a serine
(S662) to glycine mutation leads to hypophosphorylation of this
region and causes familial advanced sleep-phase disorder
(Toh et al., 2001). We hence investigated the possibility that O-
GlcNAcylation interplays with phosphorylation at S662–S674,
and tandem mass spectrometry (MS/MS) analyses were carried
out to identify O-GlcNAc sites on PER2 focusing on this region
(Figure 6A). O-GlcNAcylation can occur on S662, and this only
occurs together with O-GlcNAcylation on S671 (Figure 6A),
implying a potential antagonism of O-GlcNAcylation with phos-
phorylation in this region. Interestingly, O-GlcNAc sites found
with our method concentrate in the CK1 binding domain (S566,
S580, S653, S662, S668, S671, and T734) and in the C terminus
(T965, S983, and T1180) of PER2 (Figure 6B). To investigate
the possible interplay between phosphorylation andO-GlcNAcy-296 Cell Metabolism 17, 291–302, February 5, 2013 ª2013 Elsevier Inlation on PER2 S662–S674, HEK293 cells were transfected
with PER2-His alone or cotransfected with either OGT or OGA,
followed by immunoprecipitation with His antibody. Western
blot analysis using an antibody specific for phospho-S662
PER2 revealed that phosphorylated S662 PER2 level was
reduced in cells cotransfected with PER2 and OGT, while
O-GlcNAcylation was increased on PER2, suggesting that
O-GlcNAcylation can block S662 phosphorylation (Figure 6C).
However, neither OGT nor OGA interfered with the binding of
CK1 to PER2. PER2 peptides (Xu et al., 2007) containing either
S662 or pS662 were then used in an O-GlcNAcylation assay,
and pS662 peptides significantly reduced the capacity for
O-GlcNAcylation (Figure 6D), supporting the competitive inter-
play between phosphorylation and O-GlcNAcylation at S662.
Consistent with the finding for dClk and dPer transcriptional
activity (Figure 5A), OGT inhibited CLK-BMAL1 transcription
and further enhanced PER2 repressor activity (Figure S5). This
is congruent with the previous finding that PER2-S662G is
a stronger repressor than WT PER2 (Xu et al., 2007), and as
expected, repressor activity of PER2-S662G is not modulated
by OGT (Figure S5). Taken together, these data strongly suggest
that O-GlcNAcylation and phosphorylation compete at S662 of
PER2 to fine-tune its activity.c.
Figure 5. Functional Effects of O-GlcNAcy-
lation on dClk
(A) The effects ofOga andOgt on dClk-dependent
per-luc activity. Luciferase assayswere performed
in triplicate on at least three independent occa-
sions.
(B and C) dTim, dPer, and dOgt protein levels
under Ogt overexpression (B) and Ogt RNAi (C) as
illustrated by western analyses (left panels) and
quantifications (right panels).
(D) Quantification of Per, Tim, and VrimRNA levels
from Ogt RNAi flies by qRT-PCR. Three indepen-
dent experiments were used for each circadian
time point. Error bars represent SEM. See also
Figure S4.
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O-GlcNAc-Phospho Interplays in Circadian ClockSince O-GlcNAcylation is the direct readout for the hexos-
amine biosynthetic pathway (HBP; converting glucose to UDP-
GlcNAc), a nutrient sensing pathway through glucose, we further
investigated the impact of glucose on O-GlcNAcylation and
phosphorylation of PER2 S662, S665, and S668. We employed
an in vitro system with glucose levels that were established
previously for this analysis (Lamia et al., 2009). In the presence
of high glucose, but not low glucose, OGT was able to block
the phosphorylation by CK1d of this region (Figure 6E, right
panel, lanes 3 and 4), suggesting that high glucose levels likely
increase O-GlcNAcylation, which blocks phosphorylation of
the PER2 S662–S668 region. Intriguingly, high glucose can
significantly prevent phosphorylation even in the presence of
OGA (Figure 6E, right panel, lane 6). Given the role of PER2
S662 phosphorylation in regulating human clock (Xu et al.,
2007), these results suggest that glucose metabolism and
O-GlcNAcylation modulate the circadian clock partially through
O-GlcNAcylation’s competition with phosphorylation in the
PER2 S662 region (Figure 6F).
O-GlcNAcylation Is Regulated by Circadian Clock
Since phosphorylation and O-GlcNAcylation both modify serine
and threonine residues, and multiple phosphorylation eventsCell Metabolism 17, 291–302are known to exhibit circadian oscillation,
we set out to determine whether
O-GlcNAc modification on clock proteins
also oscillates. dClk was pulled down
from the heads of yw;;dClk-V5 flies (Me-
net et al., 2010) at different circadian
time points and then immunoblotted
with O-GlcNAc antibody. Endogenous
dClk protein underwent O-GlcNAc modi-
fication in a time-dependent manner
peaking at ZT10 (Figures 7A and 7B),
though total dClk protein levels oscillate
in the opposite phase. dPer coimmuno-
precipitated with dClk (Menet et al.,
2010) and exhibited a similar rhythmic
O-GlcNAc modification pattern (Figures
7A and 7B). Similarly, dClk and dPer
O-GlcNAcylation peaked in constant
conditions at CT10–CT14 (Figures S6A
and S6B). In addition, like what was foundfor mammalian CLOCK (Figure 4G), Oga protein coimmuopreci-
pitated with the dClk/dPer complex in vivo (Figure S6B). These
results indicate that O-GlcNAc modification is likely under circa-
dian clock regulation. We next analyzed OGT and OGA protein
expression levels from liver tissues of WT mice over circadian
time. Expression levels of OGT (110 kDa) did not oscillate.
However, OGA protein exhibited an oscillating expression
pattern that peaks around CT8–CT12 (Figure 7C) (OGA mRNA
expression also oscillates with a peak at CT2.3; http://bioinf.
itmat.upenn.edu/circa). Ogt and Oga protein levels of WT fly
heads showed expression patterns similar to mouse liver
(Figures 7D and 7E). Therefore, while OGA protein levels (and
presumably total OGA activity) oscillate in a circadian manner,
OGT protein levels are constant. But OGT activity is modulated
by GSK3b (Figure 2), and GSK3b activity is known to oscillate
through S9 phosphorylation. This would imply that OGT activity
could also oscillate. Interestingly, we found that the O-GlcNAc
on OGT itself showed a possible oscillating modification pattern
through time (Figure S6E), which supports the likelihood that
OGT activity oscillates. Taken together, these data suggest
that both OGT incorporation of donor sugar nucleotides to
proteins and OGA removal of these sugar nucleotides occur in
a circadian time-dependent manner., February 5, 2013 ª2013 Elsevier Inc. 297
Figure 6. Competition of O-GlcNAcylation
and Phosphorylation for Residues in the
PER2 S662–S674 Region
(A) MS/MS spectrum of the doubly O-GlcNAc-
modified PER2 S660–S682 region. Full-length
human PER2 was purified using FLAG affinity tag
from the HEK293 cells before being subjected to
MS/MS analysis. Modified c4 and c5 ions localize
one of the modification sites to S662, while the
mass shift between unmodified z + 111 and
modified z + 112 pinpoints the secondmodification
site to S671.
(B) MS/MS identified O-GlcNAc sites S566, S580,
S653, S662, S668, S671, T734, T965, S983, and
T1180 (labeled in red) for PER2 in the CK1 binding
domain (amino acids 557–771) and C terminus.
The identified S662, S668, and S671 O-GlcNAc
sites are also CK1 phosphorylation sites.
(C) Western blots performed with antibodies indi-
cated on the left demonstrating that the presence
of OGT inhibits PER2 S662 phosphorylation, but
the presence of either OGT or OGA does not block
CK1 binding to PER2.
(D) In vitro O-GlcNAcylation assay using affinity-
purified OGT peptides and UDP-[3H]GlcNAc.
O-GlcNAcylation of pS662 PER2 peptide is signif-
icantly reduced compared to nonphosphorylated
S662 PER2 peptide. CKII and Vangl1 peptides
served as positive and negative controls, respec-
tively. Error bars indicate the mean ± SE.
(E) The PER2 S662 region is regulated by both
O-GlcNAcylation and phosphorylation. PER2 was
transfected alone (lane 1) or with OGT (lane 2),
CK1 (lane 3), OGT and CK1 (lane 4), OGA (lane 5),
and OGA and CK1 (lane 6) in the presence of low
(left panel) or high (right panel) glucose into
HEK293 cells. Western blots of protein extracts
from these cells were probed with antibodies
indicated on the left of the panels.
(F) Proposed model for competitive regulation
by O-GlcNAcylation and phosphorylation of the
PER2 S662–S674 region. When PER2 S662–S674
is hypophosphorylated (i.e., O-GlcNAcylated), it
is known to be a stronger repressor with lower
protein stability, whereas when this region is
hyperphosphorylated, it is a weaker repressor
with higher stability (Xu et al., 2007). See also
Figure S5.
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We developed an analog-specific chemical-genetic proteomic
approach to characterize theGSK3b-dependent circadian phos-
phoproteome and identified OGT as a GSK3b substrate. Here,
we found that OGT is phosphorylated at S3 or S4 by GSK3b
and that O-GlcNAcylation of OGT also occurs on the same or
neighboring serine residues, suggesting interacting phosphory-
lation and O-GlcNAcylation events on OGT itself.
OGT is expressed constitutively, while OGA levels oscillate
with a peak around CT8–CT12, and phosphorylation of OGT by
GSK3b increases OGT activity. Given that GSK3b activity oscil-
lates through circadian time, it implies that the activity of OGT
oscillates. OGT activity is likely further regulated by additional298 Cell Metabolism 17, 291–302, February 5, 2013 ª2013 Elsevier Inmodulations including auto-O-GlcNAcylation. Intriguingly, the
O-GlcNAc modification patterns of OGT support a possibility
for oscillating OGT activity. Moreover, OGA activity may also
be regulated by other factors and posttranslational modifica-
tions. Interestingly, OGA was also identified in our GSK3b chem-
ical-genetic screen (Table S1). Together, all these pathways
contribute to the determination of O-GlcNAcylation oscillation
patterns of clock components. Hence, it is possible that the
peak of O-GlcNAc modification of clock proteins may not have
obvious correlation with the peak of OGA expression. This intri-
cate regulatory system is therefore multilayered and consistent
with the notion that delicately modulated mechanisms are
required for circadian regulation at different levels. Recently,
O-GlcNAcylation was shown to modulate both the Drosophilac.
Figure 7. O-GlcNAcylation Is Regulated
by Circadian Clock
(A) dClk was pulled down from yw;;dClk-V5 flies
(one extra copy of Clk) at different zeitgeber times
(ZT) prior to being immunoprecipitated by V5
antibody. Immunoprecipitated preparations were
run on identical gels. Western blots of these gels
were then immunoblotted by dClk, dPer, Tubulin
(left panels), and O-GlcNAc (right panels) anti-
bodies, separately.
(B) Quantification of immunoprecipitated proteins
(left panel) and O-GlcNAcylated proteins normal-
ized with immunoprecipitated protein levels (right
panel).
(C) Immunoblotting indicates that OGA protein
levels oscillate over 24 hr, and OGT expression
levels (110 kDa band) are constant over 24 hr in
extracts of mouse liver tissue.
(D) Oga shows oscillation over 24 hr, and Ogt
expression is constant in protein extracts from
WT fly heads.
(E) Quantification of (D). Error bars represent SEM.
See also Figure S6.
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O-GlcNAc-Phospho Interplays in Circadian ClockPer (Kim et al., 2012) and the mammalian BMAL1 (Durgan et al.,
2011) in regulating circadian clock. Though some discrepancies
exist among different reports, one consistent finding is the
modulation of circadian period length by the level ofO-GlcNAcy-
lation. In addition, OGT overexpression leading to reduction in
Period protein levels was found by two independent studies
(by us and the Durgan group). This modulation of PER levels
by O-GlcNAcylation could be one of the major reasons for the
observed period changes, since it has been shown that PER
rhythmic abundance is the driving force for the clock oscillation
(Chen et al., 2009; Yu et al., 2006). Additional work is needed to
identify site-specific roles of O-GlcNAcylation and then their
interplay with phosphorylation and other posttranslational modi-
fications in clock proteins in order to further reveal the complex
regulatory mechanisms of the circadian rhythms.
Protein O-GlcNAcylation has been shown to regulate tran-
scriptional machinery (Ozcan et al., 2010). For example, the
RNA polymerase (pol) II C-terminal domain is modified by both
phosphorylation and O-GlcNAcylation in a mutually exclusive
manner. It was proposed that transcriptionally inactiveO-GlcNA-
cylated RNA pol II holoenzyme localizes to promoters in a poised
state but can only effect transcriptional elongation when the
C-terminal domain O-GlcNAc is removed and becomes hyper-Cell Metabolism 17, 291–302phosphorylated upon gene activation
(Comer and Hart, 2001). It is possible
that a similar mechanism is utilized to
fine-tune the activity of Clock transcrip-
tional function. Another possibility is that
the balance between O-GlcNAcylation
and phosphorylation of Clock modulates
interactions between Clock and its
binding partners (such as repressors) in
a similar manner to what has been shown
for Myc (Kamemura et al., 2002). Our
finding that O-GlcNAcylation of the
PER2 S662 regulatory region blocksCK1-dependent PER2 phosphorylation also supports the latter
hypothesis. The phospho-O-GlcNAc switch therefore provides
a possible mechanism for tight control of the molecular clock in
order to maintain precise daily rhythms. Many questions remain,
such as how do O-GlcNAcylation and other posttranslational
modifications (in addition to phosphorylation) synergistically
regulate the intricate circadian clock? CLOCK has acetyltrans-
ferase activity and regulates chromatin remodeling through the
acetylation of BMAL1 (Hirayama et al., 2007), and Ogt has been
identified as a repressor from the polycomb complex (Gambetta
et al., 2009; Myers et al., 2011). Thus, the fact that clock proteins
are modified by OGT/OGA connects the HBP and epigenetics
(Polycomb as a protein complex for chromatin modulation) to
the circadian core clock loop. Since protein O-GlcNAcylation is
regulated principally by substrate UDP-GlcNAc availability, and
HBP (a nutrient sensor) flux is known to parallel substrate
(glucose) availability, our results showing that high glucose
blocks CK1-dependent PER2 phosphorylation (Figure 6E) raise
the intriguing possibility that the HBP and O-GlcNAc turnover
represent a glucose-dependent mechanism for regulating circa-
dian clocks and support the connection for metabolic pathways
and molecular clock. Interestingly, circadian misalignment was
shown to increase blood sugar concentrations in human (Buxton, February 5, 2013 ª2013 Elsevier Inc. 299
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O-GlcNAc-Phospho Interplays in Circadian Clocket al., 2012; Scheer et al., 2009), indicating that the timing of
nutrient intake needs to be correlated with the timing of circadian
expression of genes responsible for metabolism. Our finding that
glucose levels through O-GlcNAcylation can modulate circadian
clock protein further provides evidence that nutrient intake (and
its timing) and circadian clock have a closely maintained cooper-
ative relationship. In total, our data represent a further step
toward a greater understanding of the complex mechanisms
that control our bodily circadian functions in a highly coordinated
manner.
EXPERIMENTAL PROCEDURES
Plasmid Constructs
See Supplemental Experimental Procedures.
Kinase Assay
Nonradioactive
Glutathione S-transferase (GST) fusion of either WT GSK3b or AS GSK3b
protein was expressed in E.coli and purified by Glutathione Sepharose 4B
(GE Healthcare) (Kosuga et al., 2005). The GST tag was then removed by
PreScission Protease digestion (GE Healthcare). AS GSK3b kinase activity
was comparable to commercial GSK3b kinase activity (New England Biolabs).
For kinase assay, 100 nM recombinant WT GSK3b or AS GSK3b was used
(Allen et al., 2007). Kinase assay buffer contains 20 mM HEPES (pH 7.5),
10 mM MgCl2, 0.01 mM DTT, 0.2 mM ATPgS (or ATPgS analogs), 1 mM
GTP, and 1 mM ATP. Either 2 mg MBP or 5 mg GSK3b was used as AS
GSK3b substrate. Reactions were incubated for 10 min at room temperature
(RT) and terminated by 2.5 mM EDTA. Alkylating agent, 2 mM p-nitrobenzyl-
mesylate (PNBM), in dimethyl sulfoxide (DMSO) was added, and reactions
were incubated for 1.5 hr at room temperature. Laemmli buffer was added,
and the samples were analyzed by western blotting.
Radioactive
Recombinant human OGT protein (350 ng; OriGene) was phosphorylated by
1000 U GSK3b (New England Biolabs) for 15 min at 30C in 13 GSK3 buffer
(New England Biolabs) and supplemented with 0.5 ml 32P-labeled ATP (3,000
Ci/mmol) and 200 mM of cold ATP. For negative control reactions, OGT was
incubated without GSK3b. Proteins were separated by 4%–12% Tris-HCl
gels (Bio-Rad Laboratories) and transferred to nitrocellulose membrane for
autoradiography or western blot.
Assay for OGT Activity
Recombinant human OGT-V5, S3AS4A Ogt-V5, or S3DS4D Ogt-V5 (100 ng)
was purified from HEK293 cells. OGT was eluted with V5 peptide from the
agarose beads and was phosphorylated by GSK3b (New England Biolabs)
for 1 hr at RT in the presence of ATP in 13 GSK3b buffer with 200 mM of
cold ATP. For the unphosphorylated OGT, the reactions were carried out
without ATP. For the OGT activity assay, pOGT and OGT were incubated
with 500 mM of CKII peptide (340PGGSTPVSSANMM352) in the presence of
0.02 mCi of UDP-[3H]GlcNAc (NEN Life Science Products) in 25 mM 50 AMP,
500 mM sodium cacodylate (pH 6.0), and 10 mM 1-amino-GlcNAc (Sigma-
Aldrich). Reactions were incubated for 30 min at RT and stopped by 50 mM
formic acid. Reactions were purified with Sep-Pak C18 Vac cartridges
(Waters), peptides were eluted by methanol, and 3H incorporation to the
peptide was measured by scintillation counter. Reactions were performed
in triplicates. Phospho-662 PER2 and PER2 peptides were described
previously (Xu et al., 2007). Vangl1 peptide 517RLQSETSV524 was used as
the negative control.
Cell Culture
For transient protein expression, HEK293 cells were transfected with the
following plasmids: hPER2-His, hS662G PER2-His, hPER2-Flag, mCLOCK-
Flag, mBMAL1, hOGT-V5, hOGA-Flag, orCK1d-myc. FuGENE HD transection
reagent was used according to the manufacturer’s protocol (Roche). TAP
buffer supplemented with 100 mMPUGNAc was used for immunoprecipitation
(IP) (Angers et al., 2006). pGL3-TAT (Meijsing et al., 2009) and per2-luc plasmid300 Cell Metabolism 17, 291–302, February 5, 2013 ª2013 Elsevier In(Kaasik and Lee, 2004) were used for luciferase assay. Anti-FlagM2 Affinity Gel
(Sigma-Aldrich) or His antibody (Sigma-Aldrich) was used for pull-down.
Mouse Models
All experiments with mice were conducted according to protocols approved
by the Institutional Animal Care and Use Committee at the University of Cali-
fornia, San Francisco. GSK3bAS/AS homozygous knockin mice were obtained
from Taconic. To specifically inhibit GSK3bAS/AS with AS kinase inhibitors such
as 1-Na-PP1, GSK3bAS/AS knockin mice in wheel-running cages were en-
trained in a light/dark cycle (12 hr light/12 hr dark) for 1 week. Mice were
then released into constant darkness for 2 weeks. Intraperitoneal injection of
1 mM 1-Na-PP1 (100 mM per 25 g body weight) was given at CT12 every
day for a week beginning after 1 week in constant darkness. Ogttm1Gwh/Y
mice were a gift from Dr. J. Marth (Shafi et al., 2000). TetO-cre and actin
rtTA mice were obtained from the Jackson Laboratory (Perl et al., 2002; Sarin
et al., 2005). Five OGTF/Y/tetO-cre/and five OGTF/Y-rtTA-actin/tetO-cremice in
wheel-running cageswere entrained in a light/dark cycle (12 hr light/12 hr dark)
for 1 week. Mice were then released into constant darkness for 3 weeks, and
doxycycline hydrochloride (Sigma-Aldrich) was supplied in the drinking water
at a concentration of 2 mg/ml. The doxycyline-containing water was renewed
every 3 days. Wheel-running activity was recorded and analyzed by ClockLab.
Fly Cell Culture, Transgenic Fly, and Locomotor Behavior Analysis
Drosophila luciferase assay was carried out as described previously (Kivima¨e
et al., 2008). Knockdown and overexpression of Ogt (CG10392) and Oga
(CG5871) was performed using Drosophila. For knockdown, UAS-RNAi lines
of Ogt (18610, 18611) and Oga (41823, 41822) were obtained from the Vienna
Drosophila RNAi Center (Dietzl et al., 2007). To enhance the knockdown effect,
transgenic flies were crossedwith UAS-Dicer2. The Tim-UAS-GAL4 driver was
used to knockdown or overexpress Ogt and Oga (Blau and Young, 1999).
UAS-HA-Ogt (or UAS-Ogt) and UAS-HA-Oga (or UAS-Oga) flies were gener-
ated to overexpress Ogt and Oga using the GAL4 system (Genetic Services,
Inc). Analysis of locomotor activity of individually housed male flies (or virgin
females) was performed in constant darkness at 25C using the Drosophila
Activity Monitoring System (TriKinetics). Per0 flies were obtained from the
Drosophila Stock Center (Bloomington, IN), and yw;;Clk-V5 flies were obtained
from a previous report (Menet et al., 2010).
LumiCycle Analysis
Primary fibroblasts from Per2-luc mice (Yoo et al., 2004) at E13–E14 were ex-
tracted, cultured, and treated with 0.1 mM dexamethasone (Sigma-Aldrich) to
reset circadian clock. PUGNAc (Toronto Research Chemicals, Inc.) was used
to inhibit OGA, and Alloxan (Sigma-Aldrich) was used to inhibit OGT. Pools of
four siRNAs of OGT were used and delivered with Accell siRNA reagent to
primary Per2-luc fibroblasts (Dharmacon). Luciferase reporter activity was
measured in the LumiCycle (Actimetrics).
Statistical Analysis
Significant differences were determined by applying one-tailed or two-tailed
Student’s t tests depending on the sample types. Wheel-running activity
was compared between groups using repeated standard t tests for pairwise
comparisons. Quantitative RT-PCR (qRT-PCR) results were analyzed by
Student’s t test. Error bars indicate the mean ± SE.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, four tables, and Supple-
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Figure S1. Characterization of ASKA GSK3β, Related to Figure 1 
(A) GSK3β expression levels for WT and mutant GSK3β. V5 tagged WT GSK3β and ASKA GSK3β 
(Analog-Specific Kinase Allele, named by Taconic Artemis) were expressed in HEK293 cells and 
expression levels were probed with anti-V5 antibody. Expression levels of ASKA GSK3β are comparable 
to WT GSK3β. (B) Activity of ASKA GSK3β. HEK293 cells were transfected with WT GSK3β, ASKA 
GSK3β and K85R GSK3β (kinase dead) constructs. Kinase activities were determined on anti-V5 
immunoprecipitates (12,5-25 ug of lysate, n=4) in an in vitro kinase assay using a continuous fluorescent 
kinase assay (Omnia from Invitrogen, peptide S/T 13). ATP concentration was 1 mM. (C) Inhibition of 
ASKA GSK3β by inhibitor 1-Na-PP1. Kinase activities were determined on anti-V5 immunoprecipitates 
(25 ug of lysate) in an in vitro kinase assay using a continuous fluorescent kinas assay (Omnia from 
Invitrogen, peptide S/T 13, 20 uM ATP, n=3. 1-Na-PP1 concentration is indicated. (D) GSK3β expression 
level is similar in WT and mutant GSK3β AS/AS mice for both hippocampus and liver tissues. GSK3α is 
used for the loading control. (E) pSer55/59 Rev-erbα is reduced after 1-Na-PP1 inhibition in liver tissue at 
CT9 (left panel) suggesting the inhibition of AS-GSK3β in GSK3β AS/AS mice in vivo.  At CT19 Rev-erbα 
and pSer55/59 Rev-erbα is not present (right panel). (F) GSK3β AS/AS with or without 1-Na-PP1 treatment 
in hippocampus tissue blotted with pSer9 GSK3β antibody. Expression level of pSer9 GSK3β is similar 
before and after 1-Na-PP1 inhibition. (G) Quantification of (F), pSer9 GSK3β normalized to GSK3β ( 
n=6, 2 each genotype), p<0.05. Error bars represent SEM. 
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Figure S2. Chemical Proteomic Approach, Related to Figure 1 
(A) Method scheme:  AS-kinase (L132A GSK3β) reactions with ATPγS and ATPγS derivatives are alkylated 
with p-nitrophenzylmesylate, which creates an epitope for thiophosphate ester-specific antibody. Potential 
substrates are then immunoprecipitated with a thiophosphate ester-specific antibody, and sequenced by LC-
MS/MS. (B) WT-GSK3β catalyzes γ-phosphate transfer with ATPγS but not ATPγS analogs (N6-benzyl or N6-
phenethyl ATPγS) while AS-GSK3β (L132A) incorporates ATPγS analogs as well as ATPγS. See also Fig. 1 in 
text where AS-GSK3β (L132G) prefers ATPγS analogs over ATPγS (Figure 1C). Kinase reactions utilized 
myelin basic protein (MBP) as a substrate. *:ATPγS, B:N6-benzyl ATPγS, P:N6-phenethyl ATPγS, -:no 
nucleotides. GSK3β (last lane) from New England Biolabs was included as a positive control. Lower panel: 
total GSK3β visualized by Ponceau S staining. (C) GSK3β substrate ZO1 was immunoprecipitated at indicated 
circadian times from liver and hippocampal tissues and phosphorylated by WT GSK3β or AS-GSK3β. Western 
blot was probed with thiophosphate-ester specific antibody. IP inputs of ZO1 are shown at lower panel. (D, E) 
Examples of MS/MS for PPP1R9B and OGT.  
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Figure S3. Confirmation of Altered OGA and OGT Protein Levels under Overexpression or Knockdown 
Conditions, Related to Figure 3 
(A) OGT, O-GlcNAc and Actin levels in liver tissues from 4 independent mice with indicated genotypes 
measured by Western blotting. (B) Quantification of OGT levels in (A). Error bars represent SEM. (C) O-
GlcNAc levels from Per2-Luc fibroblasts treated with PUGNAc 100(uM) or Alloxan (1mM) for 24 hours. (D) 
Western blots of fly head extracts obtained from flies used for circadian behavior analyses shown in Figure 3D. 
Antibodies used are indicated on the left of each panel. From left to right, protein lysates of fly heads of Ogt 
knockdown (siRNA), Oga knockdown (siRNA), Ogt over-expression (oe), and Oga over-expression (oe). 
Tubulin blotting was used as loading control. OGT and OGA levels reflect the expected changes.  
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Figure S4. OGT and OGA Overexpression Specifically Alter TIM and PER Expression without Affecting 
RNA Polymerase II Activity, Related to Figure 5 
(A) Luciferase assay with pGL3–TAT promoter construct. Addition of OGA or OGT do not significantly 
(p>0.05) alter luciferase levels, demonstrating the generic effect of O-GlcNAc on RNA pol II does not impact 
the results of luciferase activity experiments. Luciferase assays were performed in triplicate on at least three 
independent occasions. Error bars represent SEM. (B) Another representative blot demonstrating Ogt 
overexpression reduces Tim and Per protein expression amplitude. Non-specific band labeled as “non-spec” in 
second panel from top. Overexpressed Ogt was detected by HA antibody in third panel and by anti-Ogt in 
fourth panel from top.  
6 
 
 
 
 
 
 
 
 
 
Figure S5. S662G PER2 Displays Enhanced Transcriptional Repressor Activity, Compared to WT 
PER2, Independent of OGT, Related to Figure 6 
OGT represses Per2-luc activity when co-transfected with WT PER2 and does not affect Per2-luc activity 
when co-transfected with S662G PER2. S662G PER2 is stronger repressor than WT PER2. Luciferase assays 
were performed in triplicate on at least three independent occasions. Error bars represent SEM. 
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Figure S6. Circadian Oscillation of O–GlcNAcylation, Related to Figure 7 
dClk and dPer are O-GlcNAc modified in vivo and dClk interacts with Oga.  dClk was immunoprecipitated 
from yw;;dClk-V5 fly heads (one extra copy of Clk) every 4 hours over 24 hour circadian time as indicated. 
Immunoprecipitated proteins were immunoblotted with antibodies recognizing O-GlcNAc, dClk, dPer, and 
Oga. Input (A) of total protein and IP (B) are shown. Quantification of immunoprecipitated total dClk and dPer 
proteins and O-GlcNAcylated dClk and dPer proteins normalized with immunoprecipitated protein levels gave 
patterns over circadian time very similar to what is shown in Figure 7B (data over zeitgeber time). (C) OGA 
antibody recognize Drosophila proteins. S2 cells transfected with or without Drosophila Oga-Flag and 
immunoblotted with antibodies against Flag tag and OGA (Sigma Prestige or Proteinteck Group, Inc). Upper 
band of the upper panel indicates Oga-Flag expression while the lower band indicates endogenous Oga when 
the blot was probed by OGA antibody. Both OGT and OGA antibodies have previously shown to recognize 
mouse proteins (Capotosti et al., 2011; Keembiyehetty et al., 2011). (D) O-GlcNAc levels from the protein 
lysates extracted from the WT fly heads over circadian time course. (E) Wheat germ agglutinin (WGA) 
pulldown from the liver tissues of the cytoplasmic fractions over the circadian time. Wheat germ agglutinin 
(WGA) is a lectin with binding specificity for GlcNAc. Antibodies used to detect the total levels and WGA 
pulldown levels are against OGT and  GAPDH.  
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Figure S7. Bioinformatic Analyses of GSK3β Interacting Proteome 
(A) GO analyses of GSK3β potential substrates/binding partners. Pie graphs for GO analysis of analog-specific 
substrates found in hippocampus only or liver only. GO entries in the inner circles are more general, while 
those in the outer circles are more specific. Between a pair of experiments, GO entries have the same colors in 
both graphs. The colors are reused every 22 unique GO entries. (B) GSK3β pathways identified with KEGG. 
The corresponding mouse ENTREZ protein IDs were used for searching the KEGG database. The size of the 
circle is proportional to the number of proteins identified from our protein list. KEGG pathways containing 
three or more proteins from our protein list are shown here with each circle representing one pathway. 
Illustrated is the O-Glycan biosynthesis pathway which includes OGT from our protein list. Pathways of similar 
types, such as metabolism or signal transduction are shown in the same background colors. 
 
 
Table S4. Locomotor Activity Rhythms of Transgenic Drosophila Lines Either Knocking Down or 
Overexpressing Ogt and Oga, Related to Figure 3 
Genotype 
tau 
(Hours) SEM (Hours) 
tim(UAS)-Gal4 (UAS)-18610 (UAS)-Dicer2/+ 21.5 0.1 
tim(UAS)-Gal4 (UAS)-18611 (UAS)-Dicer2/+ 22.1 0.06 
tim(UAS)-Gal4 (UAS)-41822 (UAS)-Dicer2/+ 23.6 0.2 
tim(UAS)-Gal4 (UAS)-41823 (UAS)-Dicer2/+ 24.9 0.1 
(UAS)-41823 23.6 0.1 
(UAS)-18610 23.5 0.09 
UAS HA-ogt (100)/ tim(UAS)-Gal4 27.3 0.3 
UAS HA-ogt (101)/ tim(UAS)-Gal4 26.7 0.1 
UAS HA-ogt (102)/ tim(UAS)-Gal4 25.5 0.1 
UAS HA-ogt (103/) tim(UAS)Gal4 26.6 0.1 
UAS HA-ogt (104)/ tim(UAS)-Gal4 26.2 0.09 
UAS HA-ogt (105)/ tim(UAS)-Gal4 25.7 0.2 
UAS HA-ogt (106)/ tim(UAS)-Gal4 25.8 0.1 
UAS ogt (200)/ tim(UAS)-Gal4 27.05 0.3 
UAS ogt (201)/ tim(UAS)-Gal4 26.05 0.08 
UAS ogt (202)/ tim(UAS)-Gal4 26.5 0.1 
UAS ogt (203)/ tim(UAS)-Gal4 26.5 0.1 
UAS ogt (209)/ tim(UAS)-Gal4 28.1 0.2 
UAS ogt (210)/ tim(UAS)-Gal4 27.1 0.2 
UAS HA-oga (300)/ tim(UAS)-Gal4 22.7 0.08 
UAS HA-oga (301)/ tim(UAS)-Gal4 23 0.04 
UAS HA-oga (303)/ tim(UAS)-Gal4 22.7 0.07 
tim(UAS)-Gal4/+ 23.9 0.02 
UAS oga (405)/ tim(UAS)-Gal4 22.8 0.05 
UAS oga (408)/ tim(UAS)-Gal4 22.9 0.05 
tim(UAS)-Gal4/+ 23.9 0.02 
 
Genotypes of flies, period length (tau) in hours are shown as indicated. At least 32 flies were used for circadian 
activity experiment from each genotype.  
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Supplemental Experimental Procedures 
 
Antibodies and Materials 
Primary antibodies used in this study are: GSK3αβ (Santa Cruz, sc-7291), GSK3β (Cell Signaling), pSer9 
GSK3β (Abcam), Rev-erbα (Cell Signaling), pSer55/59 Rev-erbα (Cell Signaling), ZO1 (Santa Cruz), 
Per2 (Alpha Diagnostic International), thioester specific antibody (Levi et al., 2007). FLAG (Sigma), V5 
(Invitrogen, Sigma), V5 antibody conjugated agarose (Abcam), anti-FLAG M2 affinity gel (Sigma), c-
myc 9E10 (Sigma), HA.11 (Covance), His (Novagen), Period and Timeless (Seghal lab), Clock (Houl et 
al., 2008), Oga (Protein Teck Group, Inc, Sigma Prestige, Santa Cruz), Ogt (Sigma, Santa Cruz), O-linked 
N-acetylglucosamine (RL2 and CDT110.6, ThermoScientific, Covance and Novus Biological), Clock 
(sc25361, Santa Cruz), Per2 (PER21A, Alpha Diagnostics), GAPDH (Santa Cruz), CK1δ (ab 48031 
Abcam), and  p662p665p668 PER2 (Shanware et al., 2011). p662PER2 antibody was made in Fu lab 
using p662 specific peptide (Toh et al., 2001).  N-6 phenethyl and benzyl ATPγS and 1-Na-PP1 inhibitor 
was provided by the Shokat lab (Levi et al., 2007). 100 mM GlcNAc (Sigma) was used as competitor for 
O-GlcNAc antibody in 5% BSA TBST overnight at 4C.  
 
Mass Spectrometry 
Gel lanes were sliced into roughly twenty bands for analysis.  Disulfide bonds were reduced using 10mM 
dithiothreitol, then alkylated using 50mM iodoacetamide, before overnight digestion with TPCK-
modified trypsin (Promega).  Extracted peptides were analyzed by LC-MS/MS using an Eksigent nano-
LC and either a QSTAR (AB Sciex) or LTQ-FT (Thermo) mass spectrometer. Peak lists were created 
using the mascot.dll (for QSTAR data) or in-house PAVA software (for LTQ-FT data).  Data were 
searched using Protein Prospector version 5.8.0.  For PNBM IPs, data was searched against a 
concatenated database of all rodent entries in UniProt downloaded on August 10th 2010 and randomized 
versions of their sequences (431542 entries).  For thio-ester IP data a concatenated database of human 
entries in UniProt downloaded on June 15th 2010 was queried (658836 entries).  QSTAR data was 
searched allowing for a precursor mass tolerance of 100 ppm and fragment mass tolerance of 0.15 Da.  
LTQ-FT data was searched allowing for a precursor mass tolerance of 30 ppm and fragment mass 
tolerance of 0.6 Da.  Cysteine residues were assumed to be carbamidomethylated, and oxidation of 
methionines, pyroglutamate formation from N-terminal glutamines and protein N-terminal acetylation 
were considered as potential modifications.  Reliability of results was assessed based on the target-decoy 
searching strategy (Elias and Gygi, 2007), and results reported had estimated protein false discovery rates 
of between 1-4 %. 
 Data for identification of post-translational modification sites on OGT was acquired by LC-
MS/MS using a Nanoacquity (Waters) UPLC system interfaced to a LTQ-Orbitrap Velos (Thermo) mass 
spectrometer. After a survey scan, the three most intense multiply charged peaks were selected for both 
HCD fragmentation (measured in the orbitrap) and ETD fragmentation (measured in the ion trap).  Data 
were searched using Protein Prospector version 5.10.0 (Mol Cell Proteomics. 2010 9(9):1795-1803) 
against all human entries in UniProt downloaded on January 11th 2011, plus randomized versions of these 
sequences (a total of 194452 entries were queried).  HCD and ETD data were searched separately. In each 
case the precursor mass tolerance was 20 ppm and all the modifications listed above were considered, 
plus additionally HexNAc modification of serine or threonine and phosphorylation of serine, threonine or 
tyrosine.  For HCD data only, neutral loss of HexNAc (i.e. where the precursor was modified but none of 
the fragment ions) was also considered.  For HCD data the fragment mass tolerance was set to 30 ppm; 
for ETD data it was set to 0.6 Da. 
 
Bioinformatic Analyses for Identified Proteins 
Gene Ontology (GO) analysis was applied to examine similarities and differences among the datasets of 
putative substrates/partners. For this purpose, protein lists from AS-GSK3β modified pulldown data sets 
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uniquely positive only from either hippocampus or liver extracts were used. The associated GO entries for 
these proteins were identified based on GO association information (org.Mm.eg.db) from Bioconductor 
(www.bioconductor.org). To visualize the overall similarities and differences (with some detail not 
shown) in the "induced" Gene Ontology categories between pairwise experiments, we used graphic 
software - Circos (http://mkweb.bcgsc.ca/circos/) to draw pie graphs (File. S3A). 
Based on Gene Set Enrichment Analysis, those GO entries that are over-represented in an 
experiment compared to the universal distribution were identified and are shown. For clarity, only GO 
entries with p-value <0.05 and containing more than 5 genes from our lists are shown. For more complete 
information, the text based GO tree files can be found in the supplementary files. Because the purpose of 
these graphs is to highlight the similarities and differences between pairwise experiments, some 
intermediate layers of GO entries are not shown if they overlap with other GO entries. As shown in File 
S3A, many proteins are of the same GO entries between the pairwise experiments (such as GO:0022892 
for hippocampus/liver) and many unique ones are also found (including GO:0030695 for hippocampus vs. 
liver).  For example, the "GO:0030695-GTPase regulatory activity" category is one of the most obvious 
differences in Gene Ontology between the hippocampus and liver results. The genes belong to 
GO:0030695 that are identified in hippocampus but not in liver include Ras GTPase activating proteins, 
Rho/Rac guanine nucleotide exchange factors and SLIT-ROBO Rho GTPase activating proteins (see 
Supplemental File S1). 
 Proteins identified in the AS-GSK3β hippocampus positive only and AS-GSK3β liver positive 
only were further examined in the KEGG database (http://www.genome.jp/kegg) to identify pathways that 
may be regulated by GSK3β. The corresponding mouse ENTREZ protein IDs were used for searching the 
KEGG database. KEGG pathways containing three or more proteins from our protein list are shown here 
(File S3B) with each circle representing one pathway.  
 
Analog-Specific Kinase Procedures 
Fresh mouse hippocampal or liver tissues extracted at different circadian times were used for kinase 
reactions. Saponin (Sigma, 10µg/ml) was added to the 1XGSK3 kinase buffer with complete protease 
inhibitors (Roche) and phosphatase inhibitors I and II (Sigma) to permeabilize cell membranes.  Tissues 
were homogenized manually. Reactions were supplied with either AS-GSK3β or WT-GSK3β, 2mM GTP, 
0.1mM ATP and 0.2mM N6-phenethyl ATPγS and were performed at room temperature for 15 min.  
After kinase assays, 2X RIPA buffer (100mM Hepes pH 7.8, 300mM NaCl, 2.0 % NP-40, 0.2 % SDS, 
20mM EDTA) with 1.5 mM PNBM was added and samples were incubated at 4°C with rocking for 2 hrs. 
PNBM was removed by size exclusion column PD-10 (Amersham Pharmacia). Protein lysates were pre-
cleared by G-Sepharose for 2 hrs (0.8mg/ml) and protein concentrations were measured with the Bradford 
method (Pierce). Proteins (0.8mg/ml) were immunoprecipitated with approximately 30 g/ml 
thiophosphate ester specific antibody at 4°C for 12-16 hrs and BSA pre-blocked protein G-Sepharose (GE 
Healthcare) was added for 2 hrs. Beads were then washed 4 times with 1X RIPA and proteins were 
separated on 4-15% SDS-PAGE (Invitrogen), stained with Colloidal Coomassie (Invitrogen) and 
analyzed by mass spectrometry. 
 
Mapping of Phosphorylation and O-GlcNAcylation Sites 
Full-length hOGT (OriGene) or OGT-FLAG were transfected and  purified using FLAG affinity tag from 
HEK293 cells and phosphorylated by GSK3β (Biolabs) in vitro. 
 
WGA Lectin Pulldown  
Liver tissues were lysed and cytoplamic fractions were extracted using Pierce cytoplasmic fraction 
extraction reagensts. For WGA pulldown 100 ug of protein was used (Vector Laboratories Inc.). 
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Plasmid Constructs 
The coding region of GSK3β was cloned into the pGEX-6P plasmid at the Bgl II/ Not I site (GE 
Healthcare). AS-GSK3β was generated by mutating the “gatekeeper” residue (L132) to A or G with the 
site-directed Quick-Change kit from Stratagene. Both alleles were used for in vitro kinase assays. The 
L132G GSK3β allele was used for the GSK3β proteomic screen with mouse tissues because of its higher 
affinity for the ATPγS analog. AS-GSK3β was cloned into the pGLUE tandem-affinity purification 
plasmid (Angers et al., 2006). Clones of Ogt (SD06381) and Oga (RE69909) were obtained from 
FlyBase.  Ogt and Oga cDNAs were cloned by PCR into the pUAST plasmid to include an HA tag.  
UAS-Ogt and UAS-Oga transgenic flies were generated using clones with or without a N-terminal HA 
tag. For S2 cell expression, Ogt, Oga, Per, Cyc, and Dbt were first cloned into the pENTR plasmid 
(Invitrogen) and fly Gateway plasmids were then obtained from the Carnegie Institution. Oga and Ogt 
were cloned into pAFW; Per was cloned into pAMW. Cyc and Dbt were cloned into the pAHW plasmid. 
dClk-V5 (Menet et al., 2010) and Tim constructs were previously published (Kivimae et al., 2008). For 
HEK293 expression, clones of mouse OGT and OGA were obtained from Open Biosystem and cloned 
into the p3XFLAG-CMV-10 plasmid (Sigma) or pcDNA6.2/V5/GW/D-TOPO (Invitrogen). Site-directed 
Quick-Change kit from Stratagene was used to generate S3AS4A OGT or S3DS4D OGt. ptGFPN1-
hPER2-myc (Xu et al., 2007) and pcDNA 3.1-Clock-Flag (Kaasik and Lee, 2004) were used. hPER2 was 
cloned into  p3XFLAG-CMV-10 plasmid (Sigma). 7.2 kb PER2 promoter were previously published 
(34). All clones were confirmed by DNA sequencing. Coding region of GSK3β was amplified by PCR 
using oligonucleotides (F)- CGGAGATCTATGTCGGGGCGACCGAGAACCAC and (R)-
CTAGCGGCCGCTCAGGTGGAGTTGGAAGCTGATGCA. All the other used oligo sequences are 
available upon request. 
 
Western Blot and Immunoprecipitation from Fly Heads 
Goat polyclonal V5-agarose (Abcam) was used to immunoprecipitate Clk from yw;; Clk-V5 flies over 
circadian time. The IP protocol was adapted from a previous report (Menet et al., 2010) with some 
modification and 100µM PUGNAc was included in the lysis solution.  
 
RNA Isolation and q-PCR 
Total RNAs were isolated from fly heads with TRIzol and further purified using RNAeasy columns 
(Qiagen). cDNAs were synthesized using Thermoscript III, and q-PCR was performed using SYBR Green 
according to the manufacture’s protocol (ABI). Oligos for q-PCR were adapted from previous reports 
(Kadener et al., 2008; Kilman et al., 2009). mRNA values from fly heads were normalized to ribosomal 
protein 49 (rp49). 
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